Meaningfully, treatment with the VCP inhibitor CB5083 or Vcp knockout in vivo, combined with anti-PD1 therapy, resulted in significant tumor suppression in mouse HCC models (Fig. 7n). The gene discussed is VCP; the disease is hepatocellular carcinoma.